enVVeno Medical (NVNO) Other Accumulated Expenses (2020 - 2026)

enVVeno Medical (NVNO) recorded quarterly Other Accumulated Expenses of $81000.0 in Q1 2026, down 39.55% quarter-over-quarter from $134000.0 in Q4 2025.

enVVeno Medical (NVNO) Other Accumulated Expenses (2020 - 2026) Analysis & Trends

enVVeno Medical's Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $81000.0 for Q1 2026.

  • In Q1 2026, Other Accumulated Expenses changed N/A year-over-year to $81000.0; the TTM figure through Mar 2026 stood at $81000.0 (changed N/A YoY), while the FY2025 annual figure was $134000.0, up 10.74% from the prior year.
  • Other Accumulated Expenses was $81000.0 for Q1 2026 at enVVeno Medical, down from $134000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $134000.0 in Q4 2025 to a low of $59000.0 in Q2 2022.
  • Historically, Other Accumulated Expenses has averaged $91000.0 across 4 years, with a median of $81000.0 in 2026.
  • Biggest YoY gain for Other Accumulated Expenses was 10.74% in 2025; the steepest drop was 10.74% in 2025.
  • A 4-year view of Other Accumulated Expenses shows it stood at $59000.0 in 2022, then surged by 105.08% to $121000.0 in 2024, then grew by 10.74% to $134000.0 in 2025, then slumped by 39.55% to $81000.0 in 2026.
  • The last three Other Accumulated Expenses figures came in at $81000.0 (Q1 2026), $134000.0 (Q4 2025), and $121000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn
10 enVVeno Medical 6.64 Mn 6.64 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 81,000.00
Dec 31, 2025 134,000.00
Dec 31, 2024 121,000.00
Jun 30, 2022 59,000.00
Mar 31, 2022 60,000.00
Dec 31, 2021 60,000.00
Dec 31, 2020 58,607.00